AAAAAA

   
Results: 1-14 |
Results: 14
The BRCA1 syndrome and other inherited breast or breast-ovarian cancers ina Norwegian prospective series
Authors: Moller, P Borg, A Heimdal, K Apold, J Vallon-Christersson, J Hovig, E Maehle, L
Citation: P. Moller et al., The BRCA1 syndrome and other inherited breast or breast-ovarian cancers ina Norwegian prospective series, EUR J CANC, 37(8), 2001, pp. 1027-1032
Genetic epidemiology of BRCA1 mutations in Norway
Authors: Moller, P Heimdal, K Apold, J Fredriksen, A Borg, A Hovig, E Hagen, A Hagen, B Pedersen, JC Maehle, L
Citation: P. Moller et al., Genetic epidemiology of BRCA1 mutations in Norway, EUR J CANC, 37(18), 2001, pp. 2428-2434
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours
Authors: Rapley, EA Crockford, GP Teare, D Biggs, P Seal, S Barfoot, R Edwards, S Hamoudi, R Heimdal, K Fossa, SD Tucker, K Donald, J Collins, F Friedlander, M Hogg, D Goss, P Heidenreich, A Ormiston, W Daly, PA Forman, D Oliver, RTD Leahy, M Huddart, R Cooper, CS Bodmer, JG Easton, DF Stratton, MR Bishop, DT
Citation: Ea. Rapley et al., Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours, NAT GENET, 24(2), 2000, pp. 197-200
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
Authors: Narod, SA Brunet, JS Ghadirian, P Robson, M Heimdal, K Neuhausen, SL Stoppa-Lyonnet, D Lerman, C Pasini, B de los Rios, P Weber, B Lynch, H
Citation: Sa. Narod et al., Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study, LANCET, 356(9245), 2000, pp. 1876-1881
Suggestive evidence for a site specific prostate cancer gene on chromosome1p36
Authors: Badzioch, M Eeles, R Leblanc, G Foulkes, WD Giles, G Edwards, S Goldgar, D Hopper, JL Bishop, DT Moller, P Heimdal, K Easton, D
Citation: M. Badzioch et al., Suggestive evidence for a site specific prostate cancer gene on chromosome1p36, J MED GENET, 37(12), 2000, pp. 947-948
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations
Authors: Borg, A Dorum, A Heimdal, K Maehle, L Hovig, E Moller, P
Citation: A. Borg et al., BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations, DIS MARKER, 15(1-3), 1999, pp. 79-84
Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations
Authors: Reichelt, JG Dahl, AA Heimdal, K Moller, P
Citation: Jg. Reichelt et al., Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations, DIS MARKER, 15(1-3), 1999, pp. 139-143
Costs and benefits of diagnosing familial breast cancer
Authors: Heimdal, K Maehle, L Moller, P
Citation: K. Heimdal et al., Costs and benefits of diagnosing familial breast cancer, DIS MARKER, 15(1-3), 1999, pp. 167-173
Efficacy of early diagnosis and treatment in women with a family history of breast cancer
Authors: Moller, P Reis, MM Evans, G Vasen, H Haites, N Anderson, E Steel, CM Apold, J Lalloo, F Maehle, L Preece, P Gregory, H Heimdal, K
Citation: P. Moller et al., Efficacy of early diagnosis and treatment in women with a family history of breast cancer, DIS MARKER, 15(1-3), 1999, pp. 179-186
Mutation-specific survival of inherited breast cancer
Authors: Moller, P Borg, A Evans, G Haites, N Steel, CM Vasen, H Gregory, H Hodgson, S Apold, J Lalloo, F Maehle, L Anderson, E Heimdal, K
Citation: P. Moller et al., Mutation-specific survival of inherited breast cancer, DIS MARKER, 15(1-3), 1999, pp. 205-205
Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
Authors: Moller, P Evans, G Haites, N Vasen, H Reis, MM Anderson, E Apold, J Hodgson, S Eccles, D Olsson, H Stoppa-Lyonnet, D Chang-Claude, J Morrison, PJ Bevilacqua, G Heimdal, K Maehle, L Lalloo, F Gregory, H Preece, P Borg, A Nevin, NC Caligo, M Steel, CM
Citation: P. Moller et al., Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer, DIS MARKER, 15(1-3), 1999, pp. 207-211
Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer
Authors: Dorum, A Heimdal, K Hovig, E Inganas, M Moller, P
Citation: A. Dorum et al., Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer, AM J HU GEN, 65(3), 1999, pp. 671-679
Prospectively detected cancer in familial breast/ovarian cancer screening
Authors: Dorum, A Heimdal, K Lovslett, K Kristensen, G Hansen, LJ Sandvei, R Schiefloe, A Hagen, B Himmelmann, A Jerve, F Shetelig, K Fjaerestad, I Trope, C Moller, P
Citation: A. Dorum et al., Prospectively detected cancer in familial breast/ovarian cancer screening, ACT OBST SC, 78(10), 1999, pp. 906-911
Risultati: 1-14 |